Figure 2. The distribution of the PRECISE‐DAPT score (A) in the whole study population (n=66 295) of patients with myocardial infarction treated with percutaneous coronary intervention and subsequent dual antiplatelet therapy, divided into score risk categories with green denoting very low risk, blue low risk, purple moderate risk, and red high risk. Kaplan‐Meier failure functions for major bleeding at 12 months stratified into 4 (B) or 2 risk categories (D). Receiver operating characteristic curve for the PRECISE‐DAPT score displaying the c‐statistic with 95% CI (C).

PRECISE‐DAPT indicates Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy.